Lv4
498 积分 2023-01-13 加入
Tetanus
2天前
已完结
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
25天前
已完结
Once-daily, single-inhaler mometasone–indacaterol– glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
25天前
已完结
Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials
26天前
已完结
The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations
27天前
已关闭
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
1个月前
已完结
Diabetes in China: epidemiology, pathophysiology and multi-omics
1个月前
已完结
Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial
1个月前
已关闭
EGFR inhibitors across generations: Progress, challenges, and future directions
1个月前
已完结
皖公网安备34019202002308
